-+ 0.00%
-+ 0.00%
-+ 0.00%

The Zhitong Finance App learned that Morgan Stanley released a research report saying that Shiyao Group (01093.HK) sales of proprietary medicines in the third quarter were slightly higher than expected, and there are several pipeline catalysts in the future to reinforce the bank's investment arguments. The bank maintains the “increase in holdings” rating of CSPC and the target price of HK$12.

Zhitongcaijing·11/20/2026 01:49:03
Listen to the news
The Zhitong Finance App learned that Morgan Stanley released a research report saying that Shiyao Group (01093.HK) sales of proprietary medicines in the third quarter were slightly higher than expected, and there are several pipeline catalysts in the future to reinforce the bank's investment arguments. The bank maintains the “increase in holdings” rating of CSPC and the target price of HK$12.